Literature DB >> 22944251

Quantitative and phenotypic analysis of mesenchymal stromal cell graft survival and recognition by microglia and astrocytes in mouse brain.

Nathalie De Vocht1, Dan Lin, Jelle Praet, Chloé Hoornaert, Kristien Reekmans, Debbie Le Blon, Jasmijn Daans, Patrick Pauwels, Herman Goossens, Niel Hens, Zwi Berneman, Annemie Van der Linden, Peter Ponsaerts.   

Abstract

Although cell transplantation is increasingly suggested to be beneficial for the treatment of various neurodegenerative diseases, the therapeutic application of such intervention is currently hindered by the limited knowledge regarding central nervous system (CNS) transplantation immunology. In this study, we aimed to investigate the early post transplantation innate immune events following grafting of autologous mesenchymal stromal cells (MSC) in the CNS of immune competent mice. First, the survival of grafted Luciferase/eGFP-expressing MSC (MSC-Luc/eGFP) was demonstrated to be stable from on day 3 post implantation using in vivo bioluminescence imaging (BLI), which was further confirmed by quantitative histological analysis of MSC-Luc/eGFP graft survival. Additional histological analyses at week 1 and week 2 post grafting revealed the appearance of (i) graft-surrounding/-invading Iba1+ microglia and (ii) graft-surrounding GFAP+ astrocytes, as compared to day 0 post grafting. While the density of graft-surrounding astrocytes and microglia did not change between week 1 and week 2 post grafting, the density of graft-invading microglia significantly decreased between week 1 and week 2 post implantation. However, despite the observed decrease in microglial density within the graft site, additional phenotypic analysis of graft-invading microglia, based on CD11b- and MHCII-expression, revealed >50% of graft-invading microglia at week 2 post implantation to display an activated status. Although microglial expression of CD11b and MHCII is already suggestive for a pro-inflammatory M1-oriented phenotype, the latter was further confirmed by: (i) the expression of NOS2 by microglia within the graft site, and (ii) the absence of arginase 1-expression, an enzyme known to suppress NO activity in M2-oriented microglia, on graft-surrounding and -invading microglia. In summary, we here provide a detailed phenotypic analysis of post transplantation innate immune events in the CNS of mice, and warrant that such intervention is associated with an M1-oriented microglia response and severe astrogliosis.
Copyright © 2012 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22944251     DOI: 10.1016/j.imbio.2012.08.266

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  16 in total

1.  Bioluminescence: a versatile technique for imaging cellular and molecular features.

Authors:  Miranda A Paley; Jennifer A Prescher
Journal:  Medchemcomm       Date:  2013-12-13       Impact factor: 3.597

2.  Expression of vascular endothelial growth factor-C (VEGF-C) and its receptor (VEGFR-3) in the glial reaction elicited by human mesenchymal stem cell engraftment in the normal rat brain.

Authors:  Yoo-Jin Shin; Tae-Ryong Riew; Joo-Hee Park; Ha-Jin Pak; Mun-Yong Lee
Journal:  J Histochem Cytochem       Date:  2014-12-03       Impact factor: 2.479

3.  Cuprizone-induced demyelination and demyelination-associated inflammation result in different proton magnetic resonance metabolite spectra.

Authors:  Jelle Praet; Jasmien Orije; Firat Kara; Caroline Guglielmetti; Eva Santermans; Jasmijn Daans; Niel Hens; Marleen Verhoye; Zwi Berneman; Peter Ponsaerts; Annemie Van der Linden
Journal:  NMR Biomed       Date:  2015-04       Impact factor: 4.044

Review 4.  Tackling the physiological barriers for successful mesenchymal stem cell transplantation into the central nervous system.

Authors:  Nathalie De Vocht; Jelle Praet; Kristien Reekmans; Debbie Le Blon; Chloé Hoornaert; Jasmijn Daans; Zwi Berneman; Annemie Van der Linden; Peter Ponsaerts
Journal:  Stem Cell Res Ther       Date:  2013-08-22       Impact factor: 6.832

5.  Interleukin-13 Gene Modification Enhances Grafted Mesenchymal Stem Cells Survival After Subretinal Transplantation.

Authors:  Libin Huang; Junmei You; Yao Yao; Maosong Xie
Journal:  Cell Mol Neurobiol       Date:  2019-12-02       Impact factor: 5.046

6.  Spatiotemporal evolution of early innate immune responses triggered by neural stem cell grafting.

Authors:  Kristien Reekmans; Nathalie De Vocht; Jelle Praet; Erik Fransen; Debbie Le Blon; Chloé Hoornaert; Jasmijn Daans; Herman Goossens; Annemie Van der Linden; Zwi Berneman; Peter Ponsaerts
Journal:  Stem Cell Res Ther       Date:  2012-12-14       Impact factor: 6.832

Review 7.  Mesenchymal stem cells migration homing and tracking.

Authors:  Abhishek Sohni; Catherine M Verfaillie
Journal:  Stem Cells Int       Date:  2013-09-30       Impact factor: 5.443

Review 8.  The glial response to intracerebrally delivered therapies for neurodegenerative disorders: is this a critical issue?

Authors:  Francesca Cicchetti; Roger A Barker
Journal:  Front Pharmacol       Date:  2014-07-10       Impact factor: 5.810

Review 9.  Increased Understanding of Stem Cell Behavior in Neurodegenerative and Neuromuscular Disorders by Use of Noninvasive Cell Imaging.

Authors:  Bryan Holvoet; Liesbeth De Waele; Mattia Quattrocelli; Olivier Gheysens; Maurillio Sampaolesi; Catherine M Verfaillie; Christophe M Deroose
Journal:  Stem Cells Int       Date:  2016-02-22       Impact factor: 5.443

10.  Immunosuppressant Drugs Mitigate Immune Responses Generated by Human Mesenchymal Stem Cells Transplanted into the Mouse Parenchyma.

Authors:  Jung Won Hwang; Su Hyeon Myeong; Na-Hee Lee; Hyeongseop Kim; Hyo Jin Son; Jong Wook Chang; Na Kyung Lee; Duk L Na
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.